Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FDL79
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $122,843
Award facts
- Contract value 100% obligated
- $122,843.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $122,843.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Keytruda 100 mg/4 ml vials. This firm fixed-price delivery order, issued on September 12, 2025, with an ultimate completion date of October 3, 2025, operates under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $500 million through November 2026. The contract does not utilize a set-aside designation, allowing DMS to compete on its merits within the broader federal pharmaceutical procurement landscape. Performance will take place at the vendor's Park Ridge facility.
DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, specializing in delivering branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare facilities nationwide. The company has consistently secured delivery orders from DLA covering an extensive portfolio of pharmaceutical products, including oncology treatments, vaccines, and specialty medications. Keytruda, an immunotherapy drug used in cancer treatment, represents the type of specialized pharmaceutical product that DMS regularly supplies to support military health operations globally.
Quick answers
Who was awarded contract SPE2DB25FDL79?
SPE2DB25FDL79 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 12, 2025.
How much is contract SPE2DB25FDL79 worth?
The government has obligated $122,843 on SPE2DB25FDL79.
Is contract SPE2DB25FDL79 an order under another contract?
Yes. SPE2DB25FDL79 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDL79 competed?
The extent of competition for SPE2DB25FDL79 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award